Hellman Jordan Management Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,708
Closed -$675K 78
2021
Q3
$675K Buy
6,708
+2,190
+48% +$220K 0.95% 41
2021
Q2
$639K Sell
4,518
-116
-3% -$16.4K 1.14% 36
2021
Q1
$462K Buy
+4,634
New +$462K 0.67% 50